M, G., SA, C., K, A., BA, B., K, F., K, H., . . . RA, M. (2022). 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis & rheumatology (Hoboken, N.J.), 74(4), 586. https://doi.org/10.1002/art.42041
Chicago Style (17th ed.) CitationM, Gorelik, et al. "2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease." Arthritis & Rheumatology (Hoboken, N.J.) 74, no. 4 (2022): 586. https://doi.org/10.1002/art.42041.
MLA (9th ed.) CitationM, Gorelik, et al. "2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease." Arthritis & Rheumatology (Hoboken, N.J.), vol. 74, no. 4, 2022, p. 586, https://doi.org/10.1002/art.42041.